Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments-Reference-Cited by-同舟云学术

Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments

Published:2016-08-29 Issue:5 Volume:175 Page:873-881
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Atwan A.¹,Ingram J.R.¹,Abbott R.²,Kelson M.J.³,Pickles T.³,Bauer A.⁴,Piguet V.¹

Affiliation:

1. Department of Dermatology & Wound Healing Cardiff Institute of Infection & Immunity Cardiff University 3rd Floor Glamorgan House Heath Park, Cardiff CF14 4XN U.K.

2. Welsh Institute of Dermatology University Hospital of Wales Cardiff U.K.

3. South East Wales Trials Unit Institute of Translation, Innovation, Methodology and Engagement Cardiff University Cardiff U.K.

4. Department of Dermatology Universitätsklinikum Carl Gustav Carus Dresden Germany

Funder

Psoriasis and Psoriatic Arthritis Alliance

National Institute for Health Research

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.14676

Reference32 articles.

1. Psoriasis

2. Treatment of psoriasis vulgaris;Schweckendiek W;Med Monatsschr,1959

3. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use

4. Dimethylfumarate for psoriasis: more than a dietary curiosity

5. Oral fumaric acid esters for psoriasis;Atwan A;Cochrane Database Syst Rev,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary habits of psoriatic patients treated with dimethyl fumarate and drug-related side effects: results from an observational study;Italian Journal of Dermatology and Venereology;2023-03

2. Fruit and vegetable wastes for biobased chemicals;Fruit and Vegetable Waste Utilization and Sustainability;2023

3. Hauterkrankungen;Arzneiverordnungs-Report 2023;2023

4. Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases;Cells;2022-12-16

5. Hauterkrankungen;Arzneiverordnungs-Report 2022;2022